FDA Panel Rejects Use of MDMA for Treatment of PTSD
An independent group of experts expressed concerns that the data from clinical trials did not outweigh risks for treatment of post-traumatic stress disorder.

Join our subscribers list to get the latest news, updates and special offers directly in your inbox
usnews Jul 4, 2024 0 231
usnews Jul 4, 2024 0 229
usnews Jul 4, 2024 0 224
usnews Jul 4, 2024 0 223
usnews Jul 4, 2024 0 222